Sponsored Symposium 2A

30 Aug 2024 11:50 12:40

Hall 301, Level 3

Company: AstraZeneca

Arvindran Alaga Chairperson Malaysia

Liam Chong Kin Speaker Malaysia

Lem Li Khen Panelist Malaysia

Time	Session

11:50 12:40	Optimising EGFR-TKI therapy: The role of combination approaches